// App-Quantinova.ai

4085 : Treatment-related toxicity and improved outcomes with immune checkpoint inhibitors in patients with hepatocellular carcinoma.

Researchers

Presenter

  • Alessio Cortellini

Principal Investigators

  • Pallavi Shruti Mishra-Kalyani

  • Yutao Gong

  • Anwaar Saeed

  • Tomi Jun

  • Sirish Dharmapuri

  • Abdul Rafeh Naqash

  • Uqba Khan

  • Ahmed Omar Kaseb

  • Yi-Hsiang Huang

  • Celina Ang

  • Julie A. Schneider

  • Anjana Pillai

  • Lorenza Rimassa

  • Richard Pazdur

  • Marc Robert Theoret

  • Steven Lemery

  • Lorraine Cheryl Pelosof

  • David James Pinato

Medical Centers

  • Department of Surgery & Cancer, Imperial College London, London, United Kingdom

  • Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, U.S. Food and Drug Administration, Silver Spring, MD, Kansas University Cancer Center, Kansas City, KS, Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, Developmental Therapeutics Clinic/Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, Weill Cornell Medical College, New York, NY, GI Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan

  • Department of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, Section of Gastroenterology, Hepatology & Nutrition, the University of Chicago Medicine, Chicago, IL

  • Humanitas University, Pieve Emanuele, Italy

  • National Cancer Institute at the National Institutes of Health, Bethesda, MD, The University of Texas Southwestern, Dallas, TX

  • Department of Surgery & Cancer, Imperial College London, London, United Kingdom

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved